Adage Capital Partners’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.6M Buy
605,905
+10,905
+2% +$533K 0.05% 357
2025
Q1
$30.3M Buy
595,000
+288,244
+94% +$14.7M 0.06% 326
2024
Q4
$13.8M Buy
306,756
+56,756
+23% +$2.56M 0.02% 531
2024
Q3
$9.28M Sell
250,000
-50,000
-17% -$1.86M 0.02% 619
2024
Q2
$9.17M Sell
300,000
-970,000
-76% -$29.7M 0.02% 619
2024
Q1
$36.9M Buy
1,270,000
+377,762
+42% +$11M 0.07% 302
2023
Q4
$24.6M Buy
892,238
+742,238
+495% +$20.5M 0.05% 366
2023
Q3
$3.36M Sell
150,000
-528,247
-78% -$11.8M 0.01% 704
2023
Q2
$27.6M Sell
678,247
-1,168,753
-63% -$47.5M 0.06% 325
2023
Q1
$89.5M Buy
+1,847,000
New +$89.5M 0.2% 123
2022
Q4
Sell
-15,000
Closed -$753K 1035
2022
Q3
$753K Sell
15,000
-45,000
-75% -$2.26M ﹤0.01% 900
2022
Q2
$2.4M Sell
60,000
-70,000
-54% -$2.8M 0.01% 870
2022
Q1
$4.85M Buy
+130,000
New +$4.85M 0.01% 835
2019
Q1
Sell
-12,000
Closed -$412K 728
2018
Q4
$412K Sell
12,000
-75,000
-86% -$2.58M ﹤0.01% 696
2018
Q3
$4.09M Buy
+87,000
New +$4.09M 0.01% 650
2016
Q3
Sell
-350,000
Closed -$2.46M 722
2016
Q2
$2.46M Buy
350,000
+100,000
+40% +$702K 0.01% 633
2016
Q1
$1.61M Buy
+250,000
New +$1.61M ﹤0.01% 649
2015
Q1
Sell
-125,000
Closed -$6.47M 746
2014
Q4
$6.47M Sell
125,000
-175,000
-58% -$9.06M 0.02% 592
2014
Q3
$13.2M Sell
300,000
-126,666
-30% -$5.57M 0.03% 480
2014
Q2
$11.2M Buy
+426,666
New +$11.2M 0.03% 509
2014
Q1
Sell
-576,666
Closed -$9.79M 726
2013
Q4
$9.79M Buy
576,666
+416,666
+260% +$7.07M 0.03% 518
2013
Q3
$3.43M Buy
+160,000
New +$3.43M 0.01% 612